Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 23Prostatic Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 3Thyroid Nodule 2Stomach Neoplasms 2Pleural Effusion, Malignant 2Mouth Neoplasms 2Fibrosis 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Uterine Hemorrhage 1Unspecified Adult Solid Tumor, Protocol Specific 1Thromboembolism 1Stomatitis 1Somatostatinoma 1Small Cell Lung Carcinoma 1Sarcoma, Endometrial Stromal 1Risk Malignant Index 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neurofibrosarcoma 1Neurofibromatosis 1 1Neoplasms 1Melanoma 1Lymphedema 1

Interventions

Capecitabine 3Trastuzumab 2Temozolomide 2Streptozocin 2Leucovorin 2Fluorouracil 2vatalanib 1tipifarnib 1regorafenib 1motesanib diphosphate 1epothilone B 1batifiban 1Thalidomide 1Sorafenib 1Pantoprazole 1Oxaliplatin 1Omeprazole 1Octreotide 1Irinotecan 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1Gefitinib 1Floxuridine 1Fentanyl 1Everolimus 1Doxorubicin 1Cisplatin 1Bortezomib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrinoma × High-Energy Shock Waves × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡